I. Kaldor

发表

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

J. Lehmann, T. Willson, S. Kliewer, 1998, Journal of medicinal chemistry.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

J. Lehmann, T. Willson, S. Kliewer, 1999, Diabetes.

Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists.

J. Caravella, D. Parks, Justin A. Caravella, 2015, Bioorganic & medicinal chemistry letters.

Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.

M. J. Bishop, J. Ambroso, J. Collins, 2013, Journal of medicinal chemistry.

Screening And Design Of Tumor Necrosis Factor-: Converting Enzyme Inhibitors

M. Lambert, T. Tippin, R. Wiethe, 2000 .

Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.

J. D. Stuart, L. Shewchuk, B. Shearer, 2015, Journal of medicinal chemistry.

Relating the structure, activity, and physical properties of ultrashort-acting benzodiazepine receptor agonists.

J. Stafford, G. J. Pacofsky, P. Feldman, 2002, Bioorganic & medicinal chemistry letters.

A scalable Nenitzescu synthesis of 2‐methyl‐4‐(trifluoromethyl)‐1H‐indole‐5‐carbonitrile

I. Kaldor, P. Turnbull, E. Boros, 2011 .

Stereocontrolled synthesis of cis-dibenzoquinolizine chlorofumarates: curare-like agents of ultrashort duration.

J. A. Ray, R. Mook, A. Sefler, 2001, The Journal of organic chemistry.

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.

J. D. Stuart, W. Harrington, B. Henke, 2015, Journal of medicinal chemistry.

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV

M. Hanlon, E. Furfine, P. Yates, 2007, Antimicrobial Agents and Chemotherapy.

Benzodiazepines a action breve

J. Stafford, G. J. Pacofsky, P. Feldman, 2000 .

Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.

Sanjay S. Patel, J. A. Ray, R. Mook, 2003, Journal of medicinal chemistry.

Alkali Carbonate Effects on N‐(2‐Hydroxyethyl)urea Cyclization: Application to a 2‐Imidazolidinone Scale‐Up

W. Kazmierski, T. Spitzer, I. Kaldor, 2013 .

Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.

Shawn P Williams, G. B. Wisely, Shawn P. Williams, 2008, Bioorganic & medicinal chemistry letters.

Thermal Synthesis of 3‐Bromothieno[3,2‐c]pyridin‐4‐(5H)‐one: A Telescoped Procedure with Tributylamine

I. Kaldor, E. Boros, 2015 .

Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.

M. Hanlon, E. Furfine, A. Shu, 2004, Biochemistry.

Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.

M. J. Bishop, J. Ambroso, J. Collins, 2013, Journal of medicinal chemistry.